Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Representatives of the World Health Organization (WHO), the European Respiratory Society (ERS) and other important organisations met in Geneva, Switzerland last week (25–26 February) to discuss how electronic and mobile devices could be used to monitor and support people with tuberculosis (TB) that smoke tobacco.
Both TB and tobacco are major global public health concerns. Evidence has also shown a strong link between TB and smoking, with smoking affecting the likelihood of infection, response to treatments, as well as rates of relapse and survival.
The meeting, organised by the WHO Global TB Programme and ERS, discussed how to harness the potential of electronic and mobile technology. In particular representatives at the meeting looked at how existing initiatives taking place in different countries can be scaled up to help fight this major public health challenge.
The outcomes of these discussions will be used in the development of new tools in the future.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79